Medicare Enrolled

Dr. Paul Karakourtis, MD

Emergency Medicine · Arlington, TX
Low-engagement
1926 SW GREEN OAKS BLVD, Arlington, TX 76017
8174725522
In practice since 2006 (19 years)
NPI: 1841237104 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Karakourtis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Karakourtis? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Karakourtis

Dr. Paul Karakourtis is an emergency medicine in Arlington, TX, with 19 years in practice.

Between the years covered by Open Payments, Dr. Karakourtis received a total of $2,202 from 33 pharmaceutical and/or device companies across 155 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in emergency medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Karakourtis is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice$ $2,202 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$2,202
Total received (2018-2024)
Avg $315/year across 7 years
Top 6% in TX for emergency medicine
33
Companies
155
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,202 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$91
2023
$294
2022
$155
2021
$51
2020
$130
2019
$592
2018
$889

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$281
Novo Nordisk Inc
$161
Lilly USA, LLC
$155
PFIZER INC.
$152
AstraZeneca Pharmaceuticals LP
$148
Allergan Inc.
$129
E.R. Squibb & Sons, L.L.C.
$100
Astellas Pharma US Inc
$98
Amgen Inc.
$87
ABBVIE INC.
$84
Teva Pharmaceuticals USA, Inc.
$82
Janssen Pharmaceuticals, Inc
$74
Abbott Laboratories
$64
Boehringer Ingelheim Pharmaceuticals, Inc.
$61
AbbVie Inc.
$50
Merck Sharp & Dohme Corporation
$50
Amarin Pharma Inc.
$45
Allergan, Inc.
$39
Shire North American Group Inc
$36
Dexcom, Inc.
$36
Ironwood Pharmaceuticals, Inc
$35
SANOFI-AVENTIS U.S. LLC
$31
Takeda Pharmaceuticals U.S.A., Inc.
$27
Insulet Corporation
$25
West-Ward Pharmaceuticals
$25
Genentech USA, Inc.
$24
Medtronic, Inc.
$19
Tris Pharma Inc
$17
Otsuka America Pharmaceutical, Inc.
$16
SANOFI PASTEUR INC.
$14
Synergy Pharmaceuticals Inc
$14
Orexigen Therapeutics, Inc.
$12
Vertical Pharmaceuticals, LLC
$11
Top 3 companies account for 27.1% of total payments
Associated products mentioned in payments ›
AJOVY · ANORO · Aimovig · BEVESPI AEROSPHERE · BEXSERO · BYSTOLIC · CHANTIX · CONTRAVE · Dexcom G6 Transmitter · Dyanavel XR · ELIQUIS · EMGALITY · FARXIGA · FLUBLOK QUADRIVALENT · FREESTYLE LIBRE · FreeStyle Libre · INVOKANA · JANUVIA · JARDIANCE · LINZESS · Linzess · METHYLPHENIDATE 72 · MOUNJARO · MYDAYIS · MYRBETRIQ · Mitigare · NATPARA (PARATHYROID HORMONE) · NUCALA · NURTEC ODT · Omnipod · Otezla · Ozempic · QULIPTA · REXULTI · SHINGRIX · SYMBICORT · Saxenda · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tresiba · Trintellix · Trulance · UBRELVY · VENASEAL · VIBERZI · VRAYLAR · Vascepa · Veozah · Victoza · Vyvanse · XARELTO · Xofluza
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for emergency medicine in TX.

Looking for a emergency medicine in Arlington?
Compare emergency medicines in the Arlington area by procedure volume, costs, and industry payment transparency.
Browse emergency medicines nearby

Geographic Context

Emergency Medicines within 10 mi
637
Per 100K population
29.8
County median income
$81,905
Nearest hospital
USMD HOSPITAL AT ARLINGTON L P
0.0 mi

Data Sources

Provider Registry✓ NPPESWeekly updates
Medicare Enrollment✓ PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments✓ Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Karakourtis is a emergency medicine, and high industry engagement (low-engagement, top 6%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Karakourtis receive payments from pharmaceutical companies?
Yes. Dr. Karakourtis received a total of $2,202 from 33 companies across 155 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Karakourtis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Emergency Medicines in Arlington
Browse emergency medicines in Arlington ranked by procedure volume and transparency data.
Highest volume
Top Emergency Medicines in TX
Emergency Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Emergency Medicines in TX
Which TX emergency medicines receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC..
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →